Piperidine

Piperidine

SCHEMBL6170163

C1CCNCC1.NS(=O)(=O)N1CCCCC1

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.71
CA1 P00915 2/20 0.71
KDM4E B2RXH2 2/20 0.58
POLB P06746 1/20 0.44
ALDH1A1 P00352 3/20 0.43
TSHR P16473 3/20 0.42
KMT2A Q03164 2/20 0.42
HTR2C P28335 2/20 0.39
HTR2B P41595 2/20 0.39
USP2 O75604 1/20 0.37
CHKA P35790 1/20 0.37
APLNR P35414 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
LMNA P02545 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperidine SCHEMBL16798704 0.93 CA2 (0.59) CA2CA1KDM4EPOLBALDH1A1
SCHEMBL30440853 0.86 KDM4E (0.58) CA2CA1KDM4EALDH1A1TSHR
SCHEMBL2017488 0.84 CA1 (1.00) CA2CA1KDM4EPOLBALDH1A1
SCHEMBL392889 0.84 CA1 (1.00) CA2CA1KDM4EPOLBALDH1A1
SCHEMBL2724764 0.84 CA1 (1.00) CA2CA1KDM4EPOLBALDH1A1
SCHEMBL21356989 0.84 CA1 (1.00) CA2CA1KDM4EPOLBALDH1A1
Hydrochloric Acid SCHEMBL9934025 0.84 KDM4E (0.56) CA2CA1KDM4EALDH1A1TSHR
SCHEMBL4532386 0.84 CA1 (0.54) CA2CA1KDM4EPOLBTSHR
SCHEMBL28174597 0.82 CA1 (0.94) CA2CA1KDM4EPOLBALDH1A1
SCHEMBL2723676 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1527051-A1 PYRIMIDYL SULPHONE AMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS Astrazeneca AB (SE) 2005-05-04 EP disclosed
WO-2004011443-A1 PYRIMIDYL SULPHONE AMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2004-02-05 WO disclosed